The Polish Association of Producers and Importers of Veterinary Medicines “POLPROWET” represents importers, producers and exclusive distributors of veterinary medicines in Poland. The veterinary pharmaceutical industry aims to provide high-quality food of animal origin and contributes to the economic growth of the country by caring for the protection of the natural environment. Polprowet represents the will of its members towards the authorities, institutions and the mass media. Thanks to the membership in IFAH-Europe, Polprowet’s activities are reflected at the community level, while supporting faster adaptation of local standards to the requirements of the European Union.
It is an honor for us to be a part of Polprowet Association.
2019? It’s been a good year for Bioceltix. A victory in the Start-Up Challenge coupled with participation in accelerator programs as well as several important congresses, conferences and rankings. A lot has happened over the past year and the next 12 months look even more exciting. Want to know ...Article
Mamstartup: Gallant has developed a non invasive method for retrieving stem cells which can be used to treat various ailments – from torn ligaments and joint inflammation to kidney disease. Poles have accomplishments when it comes to utilizing stem cells in animal treatment. PLN 5.1 ...Article
Business Insider caught up with Łukasz Bzdzion, founder of the startup Bioceltix, who – together with his team – is developing biopharmaceuticals for dogs, cats and horses. How is his company improving treatments for animals suffering from degenerative joint or autoimmune diseases? ...Article
My Company Polska has selected the 25 hottest and best startups – and we’re among them! The stem-cell-based pharmaceuticals, which Bioceltix is developing, are a safer and more effective alternative to traditional chemical-based pharmaceuticals currently on the market. Bioceltix was ...Article
Rzczpospolita: The Wroclaw-based biotech, which is working on breakthrough biopharmaceuticals intended for animals, has received additional financing in the amount of 5.1M PLN. Thanks to the grant Bioceltix, a startup, will begin working on a new project aimed at developing a stem-cell-based ...Article
2019? It’s been a good year for Bioceltix. A victory in the Start-Up Challenge coupled with participation in accelerator programs as well as ...Read full
Mamstartup: Gallant has developed a non invasive method for retrieving stem cells which can be used to treat various ailments – from torn ...Read full
Business Insider caught up with Łukasz Bzdzion, founder of the startup Bioceltix, who – together with his team – is developing ...Read full